These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33535189)

  • 21. Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke.
    Appleton JP; Woodhouse LJ; Adami A; Becker JL; Berge E; Cala LA; Casado AM; Caso V; Christensen HK; Dineen RA; Gommans J; Koumellis P; Szatmari S; Sprigg N; Bath PM; Wardlaw JM;
    Neurology; 2020 Feb; 94(5):e439-e452. PubMed ID: 31882527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.
    Pantoni L; Marzi C; Poggesi A; Giorgio A; De Stefano N; Mascalchi M; Inzitari D; Salvadori E; Diciotti S
    Neuroimage Clin; 2019; 24():101990. PubMed ID: 31491677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
    Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
    J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of small vessel disease on motor and cognitive function in Parkinson's disease.
    Shibata K; Sugiura M; Nishimura Y; Sakura H
    Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
    Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
    Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cumulative effect of small vessel disease lesions is reflected in structural brain networks of memory clinic patients.
    Heinen R; Vlegels N; de Bresser J; Leemans A; Biessels GJ; Reijmer YD;
    Neuroimage Clin; 2018; 19():963-969. PubMed ID: 30003033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta-analysis.
    Hamilton OKL; Backhouse EV; Janssen E; Jochems ACC; Maher C; Ritakari TE; Stevenson AJ; Xia L; Deary IJ; Wardlaw JM
    Alzheimers Dement; 2021 Apr; 17(4):665-685. PubMed ID: 33185327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes.
    Makin SD; Turpin S; Dennis MS; Wardlaw JM
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):893-900. PubMed ID: 23457225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Trajkovic JZ; Tomic G; Cvitan E; Sternic N
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1260-1265. PubMed ID: 30058256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incident Infarcts in Patients With Stroke and Cerebral Small Vessel Disease: Frequency and Relation to Clinical Outcomes.
    Clancy U; Arteaga-Reyes C; Jaime Garcia D; Hewins W; Locherty R; Valdés Hernández MDC; Wiseman SJ; Stringer MS; Thrippleton M; Chappell FM; Jochems ACC; Liu X; Cheng Y; Zhang J; Rudilosso S; Kampaite A; Hamilton OKL; Brown R; Bastin ME; Muñoz Maniega S; Hamilton I; Job D; Doubal FN; Wardlaw JM
    Neurology; 2024 Sep; 103(5):e209750. PubMed ID: 39159417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Computed Tomographic Biomarkers of Cerebral Small Vessel Diseases and Long-Term Outcome after Spontaneous Intracerebral Hemorrhage.
    Rodrigues MA; E Samarasekera N; Lerpiniere C; Perry LA; Moullaali TJ; J M Loan J; Wardlaw JM; Al-Shahi Salman R;
    Ann Neurol; 2021 Feb; 89(2):266-279. PubMed ID: 33145789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral small vessel disease and renal function: systematic review and meta-analysis.
    Makin SD; Cook FA; Dennis MS; Wardlaw JM
    Cerebrovasc Dis; 2015; 39(1):39-52. PubMed ID: 25547195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of, and risk factors for, cognitive impairment in lacunar stroke.
    Ohlmeier L; Nannoni S; Pallucca C; Brown RB; Loubiere L; Markus HS;
    Int J Stroke; 2023 Jan; 18(1):62-69. PubMed ID: 34983273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease.
    Lin MP; Brott TG; Liebeskind DS; Meschia JF; Sam K; Gottesman RF
    Stroke; 2020 May; 51(5):1404-1410. PubMed ID: 32248770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease.
    Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Sensitivity Cardiac Troponin T and Cognitive Function Over 12 Months After Stroke-Results of the DEMDAS Study.
    von Rennenberg R; Nolte CH; Liman TG; Hellwig S; Riegler C; Scheitz JF; Georgakis MK; Fang R; Bode FJ; Petzold GC; Hermann P; Zerr I; Goertler M; Bernkopf K; Wunderlich S; Dichgans M; Endres M;
    J Am Heart Assoc; 2024 Mar; 13(6):e033439. PubMed ID: 38456438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Small Vessel Disease Burden Is Associated With Accelerated Poststroke Cognitive Decline: A 1-Year Follow-Up Study.
    Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Seo SW; Tang WK
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):336-343. PubMed ID: 31480986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life.
    Jansen MG; Griffanti L; Mackay CE; Anatürk M; Melazzini L; Lange AG; Filippini N; Zsoldos E; Wiegertjes K; Leeuw FE; Singh-Manoux A; Kivimäki M; Ebmeier KP; Suri S
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):600-612. PubMed ID: 34610763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association between Cerebral Small Vessel Disease and the Gut Microbiome: A Cross-Sectional Analysis.
    Saji N; Murotani K; Hisada T; Tsuduki T; Sugimoto T; Kimura A; Niida S; Toba K; Sakurai T
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105568. PubMed ID: 33423868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.